Exchange: OTC·Updated 01:19 PM EDT

AKESFAkeso Inc

$13.10
$0.745
(6.03%)
Today
EarningsAug 26
Mkt Cap$11.36B
Vol1,570.00
News
all
press releases
News Placeholder
Summit Draws Frenzied Retail Chatter After Akeso Drug Shows Survival Benefit In Lung Cancer; Retail Sees More Upside
Analysts at Bernstein called the survival data “a positive surprise,” framing it as Akeso’s biggest catalyst since the drug previously outperformed Merck’s top-selling cancer therapy.
Stocktwits
<
...
1
>

Advertisement|Remove ads.